Recent work also assessed subcortical white matter lesions from post-mortem MS cases via spatial transcriptomics, finding prominent elevation of TNF signaling, in agreement with presented results in the SJL EAE model (Lerma-Martin et al., 2022). The gene discussed is TNF; the disease is myeloid sarcoma.